Hepatitis C
BioMedicines completes phase II enrollment with Omega interferon
Published in Hepatitis Weekly, June 24th, 2002
Omega interferon is a naturally occurring human interferon manufactured by BioMedicines, Inc., through genetic engineering.
"We have enrolled our 90th patient in this multicenter study," said Peter J. Langecker, MD, PhD, vice president of clinical affairs. "Because the drug has been so well tolerated to date, we have been able to continue to increase the weekly dose. Higher doses have meant higher response rates."
Mark Moran, chief executive officer, said, "Therapy with omega...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2002-06-24)
More Articles from Hepatitis Weekly
- Liver Failure
Therapies extend use of often-rejected livers for patient transplantation - Metabolism
Lack of normal cholesterol synthesis may reveal liver graft dysfunction - Antiviral Cleansing
Plasma treatment appears to be cause of hyperfibrinolysis in transplant recipients - Hepatitis B Therapy
Preliminary trial suggests emtricitabine effective against hepatitis B - Liver Toxins
Cigarette chemicals leave hepatitis B patients more prone to cancer - Pulmonary Function
Subclinical lung disease a possibility in those with hepatitis C virus - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
